Bogdanova Tetiana I, Zurnadzhy Liudmyla Yu, Nikiforov Yuri E, Leeman-Neill Rebecca J, Tronko Mykola D, Chanock Stephen, Mabuchi Kiyohiko, Likhtarov Ilya A, Kovgan Leonila M, Drozdovitch Vladimir, Little Mark P, Hatch Maureen, Zablotska Lydia B, Shpak Viktor M, McConnell Robert J, Brenner Alina V
Laboratory of Morphology of Endocrine System, State Institution 'V.P. Komisarenko Institute of Endocrinology and Metabolism of Academy of Medical Sciences of Ukraine', Vishegorodskaya Street 69, Kyiv 254114, Ukraine.
Department of Pathology, University of Pittsburgh School of Medicine, 3477 Euler Way, Pittsburgh, PA 15213, USA.
Br J Cancer. 2015 Dec 1;113(11):1556-64. doi: 10.1038/bjc.2015.372. Epub 2015 Dec 3.
There are limited data on the histopathology of papillary thyroid carcinomas (PTCs) diagnosed in irradiated populations. We evaluated the associations between iodine-131 dose and the histopathological characteristics of post-Chernobyl PTCs, the changes in these characteristics over time, and their associations with selected somatic mutations.
This study included 115 PTCs diagnosed in a Ukrainian-American cohort (n=13,243) during prescreening and four successive thyroid screenings. Of these PTCs, 65 were subjected to somatic mutation profiling. All individuals were <18 years at the time of the Chernobyl accident and had direct thyroid radioactivity measurements. Statistical analyses included multivariate linear and logistic regression.
We identified a borderline significant linear-quadratic association (P=0.063) between iodine-131 dose and overall tumour invasiveness (presence of extrathyroidal extension, lymphatic/vascular invasion, and regional or distant metastases). Irrespective of dose, tumours with chromosomal rearrangements were more likely to have lymphatic/vascular invasion than tumours without chromosomal rearrangements (P=0.020) or tumours with BRAF or RAS point mutations (P=0.008). Controlling for age, there were significant time trends in decreasing tumour size (P<0.001), the extent of lymphatic/vascular invasion (P=0.005), and overall invasiveness (P=0.026).
We determined that the invasive properties of PTCs that develop in iodine-131-exposed children may be associated with radiation dose. In addition, based on a subset of cases, tumours with chromosomal rearrangements appear to have a more invasive phenotype. The increase in small, less invasive PTCs over time is a consequence of repeated screening examinations.
关于在受辐射人群中诊断出的甲状腺乳头状癌(PTC)的组织病理学数据有限。我们评估了碘-131剂量与切尔诺贝利事故后PTC的组织病理学特征之间的关联、这些特征随时间的变化以及它们与选定体细胞突变的关联。
本研究纳入了在乌克兰裔美国人群队列(n = 13,243)的预筛查及随后四次甲状腺筛查期间诊断出的115例PTC。其中65例PTC进行了体细胞突变分析。所有个体在切尔诺贝利事故发生时年龄均小于18岁,且有直接的甲状腺放射性测量数据。统计分析包括多变量线性和逻辑回归。
我们发现碘-131剂量与总体肿瘤侵袭性(甲状腺外扩展、淋巴/血管侵犯以及区域或远处转移的存在)之间存在临界显著的线性二次关联(P = 0.063)。无论剂量如何,与无染色体重排的肿瘤(P = 0.020)或有BRAF或RAS点突变的肿瘤(P = 0.008)相比,有染色体重排的肿瘤更可能发生淋巴/血管侵犯。在控制年龄后,肿瘤大小(P < 0.001)、淋巴/血管侵犯程度(P = 0.005)和总体侵袭性(P = 0.026)存在显著的时间趋势下降。
我们确定,在暴露于碘-131的儿童中发生的PTC的侵袭特性可能与辐射剂量有关。此外,基于一部分病例,有染色体重排的肿瘤似乎具有更具侵袭性的表型。随着时间的推移,小的、侵袭性较小的PTC增多是重复筛查的结果。